These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8585761)

  • 1. Antiviral activity of recombinant interferon-alpha on hepatitis A virus replication in human liver cells.
    Crance JM; Lévêque F; Chousterman S; Jouan A; Trépo C; Deloince R
    Antiviral Res; 1995 Sep; 28(1):69-80. PubMed ID: 8585761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro.
    Crance JM; Lévêque F; Biziagos E; van Cuyck-Gandré H; Jouan A; Deloince R
    Antiviral Res; 1994 Jan; 23(1):63-76. PubMed ID: 8141593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral effect of recombinant interferon-alpha on hepatitis A virus replication in human liver cells].
    Crance JM; Deloince R; Leveque F; Jouan A; Trépo C
    C R Acad Sci III; 1994 Jan; 317(1):94-7. PubMed ID: 7987698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis A virus replication in vitro by antiviral compounds.
    Crance JM; Biziagos E; Passagot J; van Cuyck-Gandré H; Deloince R
    J Med Virol; 1990 Jun; 31(2):155-60. PubMed ID: 2167349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
    Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
    Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-cis retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor.
    Hamamoto S; Fukuda R; Ishimura N; Rumi MA; Kazumori H; Uchida Y; Kadowaki Y; Ishihara S; Kinoshita Y
    J Lab Clin Med; 2003 Jan; 141(1):58-66. PubMed ID: 12518169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of hepatitis delta virus replication to interferon-alpha treatment in transfected human cells.
    Ilan Y; Klein A; Taylor J; Tur-Kaspa R
    J Infect Dis; 1992 Nov; 166(5):1164-6. PubMed ID: 1328404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired antiviral response in human hepatoma cells.
    Keskinen P; Nyqvist M; Sareneva T; Pirhonen J; Melén K; Julkunen I
    Virology; 1999 Oct; 263(2):364-75. PubMed ID: 10544109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells.
    Kawanishi Y; Hayashi N; Katayama K; Ueda K; Takehara T; Miyoshi E; Mita E; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1995 Nov; 47(3):272-7. PubMed ID: 8551280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
    McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-alpha5 mediates stronger Tyk2-stat-dependent activation and higher expression of 2',5'-oligoadenylate synthetase than IFN-alpha2 in liver cells.
    Larrea E; Aldabe R; Riezu-Boj JI; Guitart A; Civeira MP; Prieto J; Baixeras E
    J Interferon Cytokine Res; 2004 Aug; 24(8):497-503. PubMed ID: 15320963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiviral substances on hepatitis A virus replication in vitro.
    Biziagos E; Crance JM; Passagot J; Deloince R
    J Med Virol; 1987 May; 22(1):57-66. PubMed ID: 3035080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.
    Caselmann WH; Meyer M; Scholz S; Hofschneider PH; Koshy R
    J Infect Dis; 1992 Nov; 166(5):966-71. PubMed ID: 1328410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
    Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
    Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
    Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5).
    Berthillon P; Crance JM; Leveque F; Jouan A; Petit MA; Deloince R; Trepo C
    J Hepatol; 1996 Jul; 25(1):15-9. PubMed ID: 8836896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus.
    Jordan LT; Derbyshire JB
    Vet Microbiol; 1995 Jun; 45(1):59-70. PubMed ID: 7653029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.
    Kim KI; Kim SR; Sasase N; Taniguchi M; Harada S; Kinoshita K; Kim SH; Akimoto Y; Shikata M; Kimura N; Izawa S; Ohtani A; Nakao K; Motojima M; Kinoshita M; Hirai M; Ohzu M; Hirooka T; Nabeshima S; Ishii F; Tanaka K; Hotta H
    J Clin Pharm Ther; 2006 Oct; 31(5):441-6. PubMed ID: 16958821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.
    Yang L; Kiyohara T; Kanda T; Imazeki F; Fujiwara K; Gauss-Müller V; Ishii K; Wakita T; Yokosuka O
    Virol J; 2010 Sep; 7():212. PubMed ID: 20815893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.